What changed
FDA’s Gram Peptides warning letter describes website review and alleges that offered products were unapproved new drugs.
What the evidence does not settle
Administrative correspondence is not a conviction or proof of later response or current business status.
Evidence record
Event date: 2026-03-31. Source review: inherited source synthesis; not re-audited in this expansion. Editorial publication: 2026-10-29. Original source links below retain their publication dates. These dates are not interchangeable. This is targeted source synthesis, not an exhaustive archive or a qualified clinical/legal review.
Revision history
29 October 2026: migrated from the research edition, retaining source links and evidence qualifications; not re-audited in the current expansion. Report a proposed correction through Contact us; do not include patient data.